Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Kiniksa Pharmaceuticals International, plc (KNSA)

92.24 -5.32 (-5.45%)
At close: October 30 at 4:00:01 PM EDT
92.15 -0.09 (-0.10%)
After hours: October 30 at 4:56:02 PM EDT
Trade KNSA on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
945,963
677,564
423,239
270,259
220,180
Cost of Revenue
432,576
307,218
60,910
33,407
22,895
Gross Profit
513,387
370,346
362,329
236,852
197,285
Operating Expense
382,922
293,125
407,945
262,048
187,512
Operating Income
130,465
77,221
-45,616
-25,196
9,773
Net Non Operating Interest Income Expense
--
--
--
--
1,253
Other Income Expense
15,687
11,647
9,464
8,544
1,253
Pretax Income
146,152
88,868
-36,152
-16,652
11,026
Tax Provision
36,584
29,863
7,041
-30,736
-172,337
Net Income Common Stockholders
109,568
59,005
-43,193
14,084
183,363
Diluted NI Available to Com Stockholders
109,568
59,005
-43,193
14,084
183,363
Basic EPS
1.42
0.80
-0.60
0.20
2.64
Diluted EPS
1.32
0.75
-0.60
0.20
2.60
Basic Average Shares
77,072.96
74,200.92
71,424.16
70,058.95
69,382.28
Diluted Average Shares
83,243.26
78,979.03
71,424.16
71,922.92
70,421.32
Total Operating Income as Reported
130,465
77,221
-45,616
-25,196
9,773
Total Expenses
815,498
600,343
468,855
295,455
210,407
Net Income from Continuing & Discontinued Operation
109,568
59,005
-43,193
14,084
183,363
Normalized Income
109,568
59,005
-43,193
14,084
183,363
Interest Income
--
--
--
--
1,253
Net Interest Income
--
--
--
--
1,253
EBIT
130,465
77,221
-45,616
-25,196
9,773
EBITDA
132,362
78,775
-43,921
-22,855
12,175
Reconciled Cost of Revenue
432,576
307,218
60,910
33,407
22,895
Reconciled Depreciation
1,897
1,554
1,695
2,341
2,402
Net Income from Continuing Operation Net Minority Interest
109,568
59,005
-43,193
14,084
183,363
Normalized EBITDA
132,362
78,775
-43,921
-22,855
12,175
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 5/25/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: